Sinfonia Biotherapeutics
PrivateLast Round
Grant
Dec 1, 2018
Total Funding Raised
$555,000
Company Overview
Sinfonia Biotherapeutics is a biotechnology company that develops next-generation biotherapeutics for patients suffering from pain and neurological diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sinfonia Biotherapeutics Comparables
Compare Sinfonia Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AviadoBio | 77% | |
| CombiGene AB | 76% | |
| Spur Therapeutics | 75% |
Sinfonia Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 1, 2018 | ||||
| Grant | Nov 1, 2017 |
Sinfonia Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Commission | Grant |
| Vinnova | Grant |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 1, 2018
$59K grant received from the European Commission.
Sinfonia Biotherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Sinfonia Biotherapeutics's valuation, stock price, and market status.
Is Sinfonia Biotherapeutics a public or private company?
Sinfonia Biotherapeutics is a private company.
What is the current stock price of Sinfonia Biotherapeutics?
Sinfonia Biotherapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Sinfonia Biotherapeutics worth (valuation)?
Valuation information for Sinfonia Biotherapeutics is not publicly available.
Can I buy Sinfonia Biotherapeutics stock?
Sinfonia Biotherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Sinfonia Biotherapeutics's last funding round?
Sinfonia Biotherapeutics's most recent funding round was Grant on December 1, 2018.
Who are the main investors in Sinfonia Biotherapeutics?
Key investors in Sinfonia Biotherapeutics include European Commission, Vinnova, The Michael J. Fox Foundation for Parkinson's Research.
Will Sinfonia Biotherapeutics IPO soon?
No public IPO plans have been announced for Sinfonia Biotherapeutics.
How can I track Sinfonia Biotherapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sinfonia Biotherapeutics's secondary market activity and sign up for updates.